Matrix metalloproteinase-2-containing membrane receptor complex (MMP-2 complex)

The Matrix metalloproteinase-2-containing membrane receptor complex is a specialized protein assembly found on the surface of glioblastoma cells and other neuroectodermal tumors (Deshane et al., J Biol Chem, 2003). This complex typically consists of the enzyme Matrix metalloproteinase-2 (MMP-2) tethered to the plasma membrane through interactions with Membrane-type 1 matrix metalloproteinase (MT1-MMP/MMP-14) and Tissue inhibitor of metalloproteinases-2 (TIMP-2) (UniProt P08253, P50281). Its primary biological function is to concentrate proteolytic activity at the cell surface, facilitating the degradation of the extracellular matrix, which is a critical step in tumor cell invasion and angiogenesis (Soroceanu et al., Cancer Res, 1998). In clinical oncology, this complex is the specific target of Chlorotoxin (TM-601), a peptide that binds with high affinity to the membrane-associated form of MMP-2 but not to the secreted form or to normal brain tissue (Veiseh et al., Cancer Res, 2007). Therapeutic applications include the use of Chlorotoxin-conjugated agents for intraoperative fluorescence imaging (e.g., Tozuleristide) and targeted radiotherapy, exploiting the complex's ability to undergo receptor-mediated endocytosis upon ligand binding.

Other names

MMP-2/MT1-MMP/TIMP-2 complexChlorotoxin receptorMembrane-associated MMP-2MMP-2/Annexin A2 complexSurface-expressed MMP-2 complex

Binding to the membrane-associated MMP-2 complex leads to receptor-mediated endocytosis of the complex and inhibition of gelatinase activity, facilitating the targeted delivery of imaging or therapeutic agents.